Document is current
Any future updates will be listed below
-
Authors
Zaki, Omar A.
Narayan, Raja R.
Srouji, Rami
Boerner, Thomas
Seier, Kenneth
Gönen, Mithat
Connell, Louise C.
Cercek, Andrea
Kemeny, Nancy E.
Balachandran, Vinod P.
Drebin, Jeffrey A.
Soares, Kevin C.
Kingham, T. Peter
Wei, Alice C.
Jarnagin, William R.
D’Angelica, Michael I.
-
Funding
Funding for this research was provided by:
Memorial Sloan-Kettering Cancer Center (NIH/NCI Cancer Center Support Grant P30 CA008748)
- License Information
-
More Information
Article History
Received: 4 August 2025
Accepted: 1 October 2025
First Online: 30 October 2025
Disclosure
: Dr. Connell has a consulting role with Intera Oncology. Dr. Cercek has a consulting role with Amgen, Agenus, Abbvie, Janssen, Roche, Regeneron, Daiichi, Saynko, Pfizer, Merck, GSK, and Summit. Dr. Cercek receives research grant funding from GSK and Pfizer. Dr. Drebin has stocks in IONIS Pharmaceuticals and ALNYLAM Pharmaceuticals. Dr. Wei receives research grant funding from Ipsen and is a DSMB member of Histosonics. Dr. Boerner is a current employee of Boehringer Ingelheim International GmbH, but this has no relationship to the submitted work. The remaining authors have no conflicts of interest.
